Month: July 2023

Senate Panel Seems to Be on Track To Vote Tomorrow on Bill With Language that 340B Providers Oppose

July 25, 2023 William Newton, Associate Editor/Senior Writer Views

Sens. Ron Wyden (left) and Mike Crapo's final revised PBM reform bill appears to retain language that 340B provider groups oppose.

The U.S. Senate Finance Committee apparently remains on track to vote Wednesday on a pharmacy benefit manager reform bill with [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

RWC-340B Backs Senate Bill That Would Let Ryan White Clinics Cover HIV Prevention Drugs and Services

July 25, 2023 William Newton, Associate Editor/Senior Writer Views

New U.S. Senate legislation would let Ryan White clinics voluntarily use federal grants for HIV prevention medications and associated services.

Ryan White Clinics for 340B Access (RWC-340B) last week praised a new bill in the U.S. Senate that would let [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

NACHC Names Prominent Physician with Health Center and HRSA Experience as its Leader

July 20, 2023 Tom Mirga, Editor at Large Views

NACHC has chosen Dr. Kyu Rhee, now CVS Health senior vice president and Aetna chief medical officer, to be its new president and CEO.

The National Association of Community Health Centers (NACHC) announced yesterday that its board has chosen Dr. Kyu Rhee, now CVS [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B May Cause Providers to Buy More Expensive HIV Prevention Drugs, Conservative Policy Group Says

July 20, 2023 William Newton, Associate Editor/Senior Writer Views

The American Action Forum says in a new paper that 340B incentivizes providers to favor more expensive HIV medications, "raising costs for the rest of the health care system."

The 340B drug pricing program may incentivize hospitals and other covered entities to buy expensive preventative HIV medications over low-cost [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Generic Drugmaker Amring Providing Refunds for 340B Overcharges

July 20, 2023 Tom Mirga, Editor at Large Views

Generic drug manufacturer Amring Pharmaceuticals is giving 340B covered entities refunds for overcharges on 14 products between the first quarter [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

NY FQHCs Receive $135 Million to Offset State’s 340B Medicaid Shift, While Other Providers Wait

July 20, 2023 Rich Daly, Editor in Chief Views

New York health centers are getting $135 million this week to partially replace revenue providers lost when the state implemented an April 1 shift of its Medicaid managed care drug benefits to Medicaid FFS, called NYRx.

Federally qualified health centers in New York received $135 million lump sum payments this week to partially offset expected 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Johnson & Johnson, Astellas Each Sue to Stop Medicare Drug Price Negotiations

July 20, 2023 William Newton, Associate Editor/Senior Writer Views

Johnson & Johnson and Astellas are the latest drugmakers to sue in federal court to stop Medicare drug price negotiation.

Drug manufacturers Johnson & Johnson and Astellas Pharma have each asked federal district courts to strike down parts of the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Expert Tip From Sectyr

July 20, 2023 Sponsored Content Views

Senate Panel Could Mark Up PBM Bill Next Week With Spread Pricing Language That 340B Providers Oppose

July 18, 2023 William Newton, Associate Editor/Senior Writer Views

A group of Republicans on the Senate Finance Committee have called on CMS to withdraw its plan to rewrite the definition of Medicaid best price.

The U.S. Senate Finance Committee could mark up a pharmacy benefit manager reform bill next week with Medicaid managed care [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

U.S. House Energy & Commerce Committee Drafting Drug Shortages Bill

July 18, 2023 Tom Mirga, Editor at Large Views

U.S. House Energy & Commerce Committee Chair Cathy McMorris Rodgers (R-Wash.) says the panel plans to circulate a draft drug shortage bill in the coming weeks.

The U.S. House Energy & Commerce Committee plans to circulate a draft drug shortage bill in the coming weeks, committee [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live